中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
4期
320-323
,共4页
夏素霞%唐思%张世良%董晓茜%杨瑞%王月敏
夏素霞%唐思%張世良%董曉茜%楊瑞%王月敏
하소하%당사%장세량%동효천%양서%왕월민
头孢替坦%药代动力学%液相色谱-串联质谱
頭孢替坦%藥代動力學%液相色譜-串聯質譜
두포체탄%약대동역학%액상색보-천련질보
cefotetan%pharmacokinetic%LC-MS/MS
目的:研究注射用头孢替坦二钠在中国健康人体的药代动力学。方法用开放、随机、平行、单次、单周期试验设计。30名健康受试者,男女各半,分为3组分别静脉滴注头孢替坦二钠0.5,1.0,2.0 g,用液相色谱-串联质谱测定血药浓度;用DAS 2.1软件计算药代动力学参数。结果3个剂量头孢替坦二钠的主要药代动力学参数:cmax分别为(65.25±19.84),(118.06±20.54)和(231.24±66.75)mg· L-1;tmax分别为(0.99±0.09),(0.98±0.08)和(0.97±0.12)h;t1/2分别为(4.44±0.72),(3.93±0.46)和(4.18±0.73)h;AUC0-t分别为(263.58±63.81),(421.93±48.87)和(896.99±249.78) mg· L-1· h-1。1.0 g剂量组给药后同时收集尿液,24 h尿排率为(65.62±10.23)%。结论头孢替坦二钠的血药浓度-时间曲线符合二室模型,其剂量在0.5~2.0g安全。
目的:研究註射用頭孢替坦二鈉在中國健康人體的藥代動力學。方法用開放、隨機、平行、單次、單週期試驗設計。30名健康受試者,男女各半,分為3組分彆靜脈滴註頭孢替坦二鈉0.5,1.0,2.0 g,用液相色譜-串聯質譜測定血藥濃度;用DAS 2.1軟件計算藥代動力學參數。結果3箇劑量頭孢替坦二鈉的主要藥代動力學參數:cmax分彆為(65.25±19.84),(118.06±20.54)和(231.24±66.75)mg· L-1;tmax分彆為(0.99±0.09),(0.98±0.08)和(0.97±0.12)h;t1/2分彆為(4.44±0.72),(3.93±0.46)和(4.18±0.73)h;AUC0-t分彆為(263.58±63.81),(421.93±48.87)和(896.99±249.78) mg· L-1· h-1。1.0 g劑量組給藥後同時收集尿液,24 h尿排率為(65.62±10.23)%。結論頭孢替坦二鈉的血藥濃度-時間麯線符閤二室模型,其劑量在0.5~2.0g安全。
목적:연구주사용두포체탄이납재중국건강인체적약대동역학。방법용개방、수궤、평행、단차、단주기시험설계。30명건강수시자,남녀각반,분위3조분별정맥적주두포체탄이납0.5,1.0,2.0 g,용액상색보-천련질보측정혈약농도;용DAS 2.1연건계산약대동역학삼수。결과3개제량두포체탄이납적주요약대동역학삼수:cmax분별위(65.25±19.84),(118.06±20.54)화(231.24±66.75)mg· L-1;tmax분별위(0.99±0.09),(0.98±0.08)화(0.97±0.12)h;t1/2분별위(4.44±0.72),(3.93±0.46)화(4.18±0.73)h;AUC0-t분별위(263.58±63.81),(421.93±48.87)화(896.99±249.78) mg· L-1· h-1。1.0 g제량조급약후동시수집뇨액,24 h뇨배솔위(65.62±10.23)%。결론두포체탄이납적혈약농도-시간곡선부합이실모형,기제량재0.5~2.0g안전。
Objective To study the pharmacokinetics of cefotetan diso-dium injection in Chinese healthy volunteers.Methods The study was designed as an open , randomized , parallel and single-dose single cycle study.Thirty healthy volunteers were divided into three groups.Each group included five volunteers male and five female volunteers.The vol-unteers in different groups were administered with single dose of 0.5 , 1.0 or 2.0 g cefotetan disodium , respectively.Plasma concentrations of cefotetan disodium were determined by LC -MS/MS method.The phar-macokinetic parameters of cefotetan disodium were calculated by DAS version 2.1 software.Results The main pharmacokinetic parameters of three doses (0.5, 1.0, 2.0 g)of cefotetan disodium were as follows:cmax were(65.25 ±19.84), (118.06 ±20.54), (231.24 ±66.75)mg· L-1;tmax were(0.99 ±0.09), (0.98 ±0.08), (0.97 ±0.12)h; t1/2 were(4.44 ±0.72 ), (3.93 ±0.46 ), (4.18 ±0.73 ) h; AUC0-t were ( 263.58 ± 63.81 ) , ( 421.93 ± 48.87 ) , ( 896.99 ± 249.78 ) mg· L-1 · h -1 , respectively.Urinary recovery rate within 24 h was (65.62 ±10.23 )%.Conclusion The plasma concentration - time curve fits two compartment model.The safe dose was 0.5-2.0 g.